Nuvation Bio Inc. SEC filings NUVB
Nuvation Bio Inc. has 400 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 29, 2026 | — |
| FWP | Free writing prospectus | Jun 26, 2026 | — |
| 424B5 | Prospectus supplement | Jun 25, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| S-8 | Employee stock plan registration | Nov 3, 2025 | — |
| S-3ASR | Automatic shelf registration | Mar 6, 2025 | — |
| 424B3 | Prospectus | Aug 15, 2024 | — |
| S-3 | Shelf registration | Aug 5, 2024 | — |
| S-8 | Employee stock plan registration | Apr 18, 2024 | — |
| S-8 | Employee stock plan registration | Mar 4, 2024 | — |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| S-8 | Employee stock plan registration | Aug 26, 2022 | — |
| 424B3 | Prospectus | Apr 11, 2022 | — |
| POS AM | Filing | Mar 2, 2022 | — |
| 424B3 | Prospectus | Feb 1, 2022 | — |
| 424B3 | Prospectus | Jan 10, 2022 | — |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 424B3 | Prospectus | Aug 12, 2021 | — |
| S-8 | Employee stock plan registration | Jun 8, 2021 | — |
| 424B3 | Prospectus | Jun 2, 2021 | — |
| POS AM | Filing | May 25, 2021 | — |
| 424B3 | Prospectus | Mar 31, 2021 | — |
| S-1/A | Amended registration statement | Mar 29, 2021 | — |
| S-1 | Registration statement | Mar 11, 2021 | — |
| 424B3 | Prospectus | Jan 20, 2021 | — |
| S-4/A | Amendment no. 3 to form s-4 | Jan 19, 2021 | — |
| S-4/A | Amendment no. 2 to form s-4 | Jan 8, 2021 | — |
| S-4/A | Amendment no. 1 to form s-4 | Dec 18, 2020 | — |
| S-4 | Registration for a merger or exchange | Nov 12, 2020 | — |
| 424B4 | Prospectus | Jul 2, 2020 | — |
| S-1/A | Amended registration statement | Jun 23, 2020 | — |
| S-1 | Registration statement | Jun 12, 2020 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NUVB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1811063
- Former names
- Panacea Acquisition Corp (until Feb 11, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.